Klingemann, Hans
ImmunityBio,
United States
2024 Rank: 48534
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 978 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48534 | 50855 |
| Total Cites | 651 | 700 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 34 | 34 |
| Total Cites to Single Authored Papers | 44 | 46 |
| Number of Single+First Authored Papers | 99 | 99 |
| Total Cites to Single+First Authored Papers | 110 | 114 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 222 | 231 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 468 | 473 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.48 |
| Self-Citation Percentage |
7.00%
|
|
Klingemann, Hans
ImmunityBio,
United States
2023 Rank: 39412
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 895 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39412 | 42814 |
| Total Cites | 788 | 808 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 41 | 42 |
| Number of Single+First Authored Papers | 98 | 98 |
| Total Cites to Single+First Authored Papers | 116 | 117 |
| Number of Single+First+Last Authored Papers | 142 | 142 |
| Total Cites to Single+First+Last Authored Papers | 261 | 266 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 535 | 546 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.48 |
| Self-Citation Percentage |
2.48%
|
|
Klingemann, Hans
Inc,
United States
2022 Rank: 22072
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 594 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22072 | 25819 |
| Total Cites | 945 | 971 |
| H-index | 16 | 16 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 51 | 51 |
| Number of Single+First Authored Papers | 97 | 97 |
| Total Cites to Single+First Authored Papers | 140 | 141 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 338 | 339 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 628 | 639 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.52 |
| Self-Citation Percentage |
2.68%
|
|
Klingemann, Hans
NantKwest, Inc.,
United States
2020 Rank: 25824
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 593 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25824 | 30294 |
| Total Cites | 1069 | 1111 |
| H-index | 15 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 31 | 31 |
| Total Cites to Single Authored Papers | 58 | 58 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 163 | 163 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 341 | 342 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 716 | 734 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.51 |
| Self-Citation Percentage |
3.78%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.